Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Sinil Pharm Co., Ltd. (012790:KRX), powered by AI.
Sinil Pharm Co., Ltd. is currently trading at ₩5,410. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Sinil Pharm Co., Ltd. on Alpha Lenz.
Sinil Pharm Co., Ltd.'s P/E ratio is 8.6.
“Sinil Pharm Co., Ltd. trades at a P/E of 8.6 (undervalued) with modest ROE of 5.0%.”
Ask for details →Sinil Pharm Co., Ltd. is a pharmaceutical company dedicated to the development, manufacture, and distribution of a diverse range of pharmaceutical products. Sinil Pharm focuses on producing both prescription medications and over-the-counter drugs, addressing various therapeutic areas and contributing to public health. Key areas of production include analgesics, antibiotics, and lifestyle-related medications, providing essential healthcare solutions to a broad spectrum of customers. As an integral player in the pharmaceutical industry, Sinil Pharm Co., Ltd. supplies its products to hospitals, clinics, and pharmacies, ensuring accessibility to quality medical solutions. The company's role in the market is pivotal as it supports healthcare systems by offering reliable and affordable pharmaceuticals. Sinil Pharm Co., Ltd.'s continued commitment to innovation and adherence to regulatory standards underscores its importance in the global pharmaceutical landscape.
“Sinil Pharm Co., Ltd. trades at a P/E of 8.6 (undervalued) with modest ROE of 5.0%.”
Ask for details →Sinil Pharm Co., Ltd. (ticker: 012790) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). Market cap is $64.8B.
The current price is ₩5,410 with a P/E ratio of 8.61x and P/B of 0.43x.
ROE is 5.04% and operating margin is 9.17%. Annual revenue is $80.6B.